508 related articles for article (PubMed ID: 33192051)
1. Pharmacological Activity and Mechanism of Tanshinone IIA in Related Diseases.
Guo R; Li L; Su J; Li S; Duncan SE; Liu Z; Fan G
Drug Des Devel Ther; 2020; 14():4735-4748. PubMed ID: 33192051
[No Abstract] [Full Text] [Related]
2. A comprehensive review of tanshinone IIA and its derivatives in fibrosis treatment.
Bi Z; Wang Y; Zhang W
Biomed Pharmacother; 2021 May; 137():111404. PubMed ID: 33761617
[TBL] [Abstract][Full Text] [Related]
3. Tanshinone IIA attenuates neuroinflammation via inhibiting RAGE/NF-κB signaling pathway in vivo and in vitro.
Ding B; Lin C; Liu Q; He Y; Ruganzu JB; Jin H; Peng X; Ji S; Ma Y; Yang W
J Neuroinflammation; 2020 Oct; 17(1):302. PubMed ID: 33054814
[TBL] [Abstract][Full Text] [Related]
4. A network pharmacology approach to investigate the anti-inflammatory mechanism of effective ingredients from Salvia miltiorrhiza.
Cui S; Chen S; Wu Q; Chen T; Li S
Int Immunopharmacol; 2020 Apr; 81():106040. PubMed ID: 31818704
[TBL] [Abstract][Full Text] [Related]
5. Direct vasorelaxation by a novel phytoestrogen tanshinone IIA is mediated by nongenomic action of estrogen receptor through endothelial nitric oxide synthase activation and calcium mobilization.
Fan G; Zhu Y; Guo H; Wang X; Wang H; Gao X
J Cardiovasc Pharmacol; 2011 Mar; 57(3):340-7. PubMed ID: 21383591
[TBL] [Abstract][Full Text] [Related]
6. Tanshinone-IIA mediated neuroprotection by modulating neuronal pathways.
Sherawat K; Mehan S
Naunyn Schmiedebergs Arch Pharmacol; 2023 Aug; 396(8):1647-1667. PubMed ID: 37010572
[TBL] [Abstract][Full Text] [Related]
7. Tanshinone IIA induces ferroptosis in gastric cancer cells through p53-mediated SLC7A11 down-regulation.
Guan Z; Chen J; Li X; Dong N
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32776119
[TBL] [Abstract][Full Text] [Related]
8. Tanshinone IIA protects intestinal epithelial cells from deoxynivalenol-induced pyroptosis.
Zhang C; Chen F; Wang Y; Zhang K; Yang X; Wang X
Ecotoxicol Environ Saf; 2024 Jan; 269():115743. PubMed ID: 38035519
[TBL] [Abstract][Full Text] [Related]
9. Tanshinone ⅡA inhibits homocysteine-induced proliferation of vascular smooth muscle cells via miR-145/CD40 signaling.
Li Y; Chen F; Guo R; Jia S; Li W; Zhang B
Biochem Biophys Res Commun; 2020 Jan; 522(1):157-163. PubMed ID: 31757424
[TBL] [Abstract][Full Text] [Related]
10. Specific Degradation of Endogenous Tau Protein and Inhibition of Tau Fibrillation by Tanshinone IIA through the Ubiquitin-Proteasome Pathway.
Cai N; Chen J; Bi D; Gu L; Yao L; Li X; Li H; Xu H; Hu Z; Liu Q; Xu X
J Agric Food Chem; 2020 Feb; 68(7):2054-2062. PubMed ID: 31995984
[TBL] [Abstract][Full Text] [Related]
11. Prospective therapeutic potential of Tanshinone IIA: An updated overview.
Ansari MA; Khan FB; Safdari HA; Almatroudi A; Alzohairy MA; Safdari M; Amirizadeh M; Rehman S; Equbal MJ; Hoque M
Pharmacol Res; 2021 Feb; 164():105364. PubMed ID: 33285229
[TBL] [Abstract][Full Text] [Related]
12. Tanshinone IIA: New Perspective on the Anti-Tumor Mechanism of A Traditional Natural Medicine.
Zhang W; Liu C; Li J; Lu Y; Li H; Zhuang J; Ren X; Wang M; Sun C
Am J Chin Med; 2022; 50(1):209-239. PubMed ID: 34983327
[TBL] [Abstract][Full Text] [Related]
13. Tanshinone IIA alleviates acute ethanol-induced myocardial apoptosis mainly through inhibiting the expression of PDCD4 and activating the PI3K/Akt pathway.
Deng H; Yu B; Li Y
Phytother Res; 2021 Aug; 35(8):4309-4323. PubMed ID: 34169595
[TBL] [Abstract][Full Text] [Related]
14. Tanshinone IIA exhibits anti-inflammatory and antioxidative effects in LPS-stimulated bovine endometrial epithelial cells by activating the Nrf2 signaling pathway.
Fu K; Feng C; Shao L; Mei L; Cao R
Res Vet Sci; 2021 May; 136():220-226. PubMed ID: 33689878
[TBL] [Abstract][Full Text] [Related]
15. Analysis of tanshinone IIA induced cellular apoptosis in leukemia cells by genome-wide expression profiling.
Liu C; Li J; Wang L; Wu F; Huang L; Xu Y; Ye J; Xiao B; Meng F; Chen S; Yang M
BMC Complement Altern Med; 2012 Jan; 12():5. PubMed ID: 22248096
[TBL] [Abstract][Full Text] [Related]
16. Targeting the Ang2/Tie2 Axis with Tanshinone IIA Elicits Vascular Normalization in Ischemic Injury and Colon Cancer.
Zou W; Qian C; Zhang S; Wan X; Wei Z; Li X; Wu Y; Chen W; Wang A; Zhao Y; Lu Y
Oxid Med Cell Longev; 2021; 2021():7037786. PubMed ID: 34804370
[TBL] [Abstract][Full Text] [Related]
17. Tanshinone IIA Regulates Keap1/Nrf2 Signal Pathway by Activating Sestrin2 to Restrain Pulmonary Fibrosis.
Li H; Wu M; Guo C; Zhai R; Chen J
Am J Chin Med; 2022; 50(8):2125-2151. PubMed ID: 36309810
[TBL] [Abstract][Full Text] [Related]
18. Tanshinone IIA targeting cell signaling pathways: a plausible paradigm for cancer therapy.
Alam SSM; Samanta A; Uddin F; Ali S; Hoque M
Pharmacol Rep; 2023 Aug; 75(4):907-922. PubMed ID: 37440106
[TBL] [Abstract][Full Text] [Related]
19. Tanshinone II A attenuates inflammatory responses of rats with myocardial infarction by reducing MCP-1 expression.
Ren ZH; Tong YH; Xu W; Ma J; Chen Y
Phytomedicine; 2010 Mar; 17(3-4):212-8. PubMed ID: 19800776
[TBL] [Abstract][Full Text] [Related]
20. Tanshinone IIA attenuates cerebral aneurysm formation by inhibiting the NF‑κB‑mediated inflammatory response.
Ma J; Hou D; Wei Z; Zhu J; Lu H; Li Z; Wang X; Li Y; Qiao G; Liu N
Mol Med Rep; 2019 Aug; 20(2):1621-1628. PubMed ID: 31257487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
